[1]. World Health Organization. Squalene-based adjuvants in vaccines. Disponível em: http://www.who.int/vaccine_safety/topics/adjuvants/squalene/questions_and_answers/en/index.html (acedido a 7/5/2010)
[2]. Kalvodova L. Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation. Biochemical and Biophysical Research Communications, Volume 393, Issue 3, 12 March 2010, Pages 350-355
[3]. Reddy L., Couvreur P. Squalene A natural triterpene for use in disease management and therapy. Advanced Drug Delivery Reviews, Volume 61, Issue 15, 17 December 2009, Pages 1412-1426
[4]. Del Giudice G., Fragapane E., Bugarini R., Hora M., Henriksson T., Palla E., Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene. Clinical and vaccine immunology :, Sept. 2006, p. 1010–1013
[5]. Phillips CJ, Matyas GR, Hansen CJ, Alving CR. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness Vaccine, Volume 27, Issue 29, 12 June 2009, Pages 3921-3926
[6]. L. Harivardhan Reddy, Couvreur P., Squalene: A natural triterpene for use in disease management and therapy, Advanced Drug Delivery Reviews 61 (2009) 1412–1426
[7]. Ficha técnica do adjuvante MF59 – NOVARTIS. Disponível em: http://www.novartis.com/downloads/newsroom/MF59-Adj-fact-sheet.pdf (acedido a 7/5/2010)
[8]. Lippi G., Targher G., Franchini M. Vaccination, squalene and anti-squalene antibodies: Facts or fiction?, European Journal of Internal Medicine 21 (2010) 70–73
[9]. The Merck Index. Disponível em: https://themerckindex.cambridgesoft.com/TheMerckIndex/default.asp?formgroup=basenp_form_group&dataaction=db&dbname=TheMerckIndex (acedido a 12/05/10)
[10]. Infarmed. Disponível em: http://www.infarmed.pt/infomed/download_ficheiro.php?med_id=30061&tipo_doc=fi (acedido a 7/5/2010)
[11]. European medicines agency. Disponível em: http://www.ema.europa.eu/humandocs/PDFs/EPAR/pandemrix/D-H1N1%20single%20PDFs/PackageLeaflet/emea-pl-h832pu17pt.pdf (acedido a 7/5/2010)
[12]. Kuroda Y. et al, Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine, Biomedicine & Pharmacotherapy 58 (2004) 325–337
[13]. European medicines agency. Disponível em: http://www.ema.europa.eu/humandocs/PDFs/EPAR/focetria/package_leaflet/emea-pl-h710pt.pdf (acedido a 7/5/2010)
